Winter 2020 (Volume 30, Number 4)
Update from the
Guidelines Committee
By Glen Hazlewood, MD, FRCPC
Download PDF
Over the past year, the Guidelines Committee
has continued to work towards developing and
updating CRA treatment recommendations,
driven by our membership.
Highlights in the past year include:
- The JIA-Uveitis group, led by Drs. Bobbi Berard
and Deb Levy, met over the summer to develop
CRA treatment recommendations, adapting those
from other organizations to a Canadian context.
The Zoom meetings went well, with excellent
engagement from the panel. Guidelines are now
being written and should be published in early
2021.
- Recommendations for rheumatoid arthritis are
underway, with the guideline panel meeting
monthly to vote on recommendations, which will
be published in a ‘living’ fashion, starting in early
2021.
- Spondyloarthritis Guidelines, led by Dr. Sherry
Rohekar, are ongoing, with plans to also use an
adapt/adopt approach from other guidelines, with
updated literature searches.
- Our ongoing equity initiative, led by Dr. Cheryl
Barnabe, has led to a draft Equity Framework, which
will be incorporated into CRA Guidelines, starting
in 2021.
- We have continued to foster and build
relationships with other international
rheumatology and guidelines associations to
harmonize efforts, including Cochrane, GRADE,
ACR and the Australian Rheumatology Association.
Thank you to everyone for their hard work
over the past year, despite the challenging
times. I think I speak for everyone when I say
we’re looking forward to 2021!
Glen Hazlewood, MD, FRCPC
Associate Professor,
Departments of Medicine and Community Health Sciences,
Cumming School of Medicine,
University of Calgary,
Calgary, Alberta
|
